Physician input needed: Do you prescribe semaglutide or other GLP-1RAs?

Take our quick survey

One of the hottest topics in medicine right now is the potentially revolutionary use of Glucagon-like peptide-1 receptor agonist (GLP-1RAs) drugs to manage overweight/obesity. These medicines are popularly known to patients by brand names like Ozempic or Wegovy.

We value your expertise! We're conducting a brief survey to gather insights from physicians like you on physician use and perceptions of GLP-1RA drugs for managing obesity.

Your feedback will be instrumental in helping us create content to inform physicians about this rapidly developing space.

The survey takes only 5 minutes to complete, and all responses are anonymous.

Click here to participate